# Psilocybin Microdose for Psychological and Existential Distress in Palliative Care (PSYCHED-PAL-RCT)

> **NCT07063862** · PHASE3 · RECRUITING · sponsor: **Bruyère Health Research Institute.** · enrollment: 120 (estimated)

## Conditions studied

- Psychological Distress

## Interventions

- **DRUG:** Psilocybin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07063862
- **Lead sponsor:** Bruyère Health Research Institute.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2026-08
- **Final completion:** 2027-09
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07063862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07063862, "Psilocybin Microdose for Psychological and Existential Distress in Palliative Care (PSYCHED-PAL-RCT)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07063862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*